Literature DB >> 27357931

Adipocytes, aldosterone and obesity-related hypertension.

Aurelie Nguyen Dinh Cat1, Malou Friederich-Persson2, Anna White2, Rhian M Touyz1.   

Abstract

Understanding the mechanisms linking obesity with hypertension is important in the current obesity epidemic as it may improve therapeutic interventions. Plasma aldosterone levels are positively correlated with body mass index and weight loss in obese patients is reported to be accompanied by decreased aldosterone levels. This suggests a relationship between adipose tissue and the production/secretion of aldosterone. Aldosterone is synthesized principally by the adrenal glands, but its production may be regulated by many factors, including factors secreted by adipocytes. In addition, studies have reported local synthesis of aldosterone in extra-adrenal tissues, including adipose tissue. Experimental studies have highlighted a role for adipocyte-secreted aldosterone in the pathogenesis of obesity-related cardiovascular complications via the mineralocorticoid receptor. This review focuses on how aldosterone secretion may be influenced by adipose tissue and the importance of these mechanisms in the context of obesity-related hypertension.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  adipocytes; aldosterone; obesity-related hypertension; synthesis

Mesh:

Substances:

Year:  2016        PMID: 27357931     DOI: 10.1530/JME-16-0025

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  18 in total

Review 1.  Sex Differences in Mechanisms of Hypertension Associated With Obesity.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

2.  Serum Amyloid P and a Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin Ligand Inhibit High-Fat Diet-Induced Adipose Tissue and Liver Inflammation and Steatosis in Mice.

Authors:  Darrell Pilling; Nehemiah Cox; Megan A Thomson; Tejas R Karhadkar; Richard H Gomer
Journal:  Am J Pathol       Date:  2019-09-18       Impact factor: 4.307

Review 3.  Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease.

Authors:  Guanghong Jia; Warren Lockette; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-01-13       Impact factor: 3.619

Review 4.  The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.

Authors:  Guanghong Jia; Annayya R Aroor; James R Sowers
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

Review 5.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

6.  Sex Differences in Diurnal Sodium Handling During Diet-Induced Obesity in Rats.

Authors:  Reham H Soliman; Chunhua Jin; Crystal M Taylor; Emile Moura Coelho da Silva; David M Pollock
Journal:  Hypertension       Date:  2022-05-12       Impact factor: 9.897

Review 7.  Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.

Authors:  Badhma Valaiyapathi; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

8.  Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.

Authors:  Gregory L Hundemer; Rene Baudrand; Jenifer M Brown; Gary Curhan; Gordon H Williams; Anand Vaidya
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

Review 9.  Roles of Perivascular Adipose Tissue in Hypertension and Atherosclerosis.

Authors:  Hengjing Hu; Minerva Garcia-Barrio; Zhi-Sheng Jiang; Yuqing Eugene Chen; Lin Chang
Journal:  Antioxid Redox Signal       Date:  2020-06-02       Impact factor: 8.401

Review 10.  Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication.

Authors:  Gashaw Dessie; Birhanu Ayelign; Yonas Akalu; Tewodros Shibabaw; Meseret Derbew Molla
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-17       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.